ASTIMS: Autologous Stem cell Transplantation International Multiple Sclerosis

Trial Profile

ASTIMS: Autologous Stem cell Transplantation International Multiple Sclerosis

Discontinued
Phase of Trial: Phase II

Latest Information Update: 09 Nov 2012

At a glance

  • Drugs Mitoxantrone (Primary) ; Autologous stem cell therapy; Carmustine; Cytarabine; Etoposide; Haematopoietic stem cell therapy; Melphalan
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms ASTIMS
  • Most Recent Events

    • 09 Nov 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top